Foundation for Innovative New Diagnostics

Tweet this page
<
2021
2022
2023
2024
>
Registration as it was on 27 Nov 2024
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

1.25 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Foundation for Innovative New Diagnostics   (FIND)

    EU Transparency Register

    158922541572-78 First registered on 01 Mar 2021

    Goals / Remit

    We are a global non-profit organization driving innovation in the development and delivery of diagnostics to combat major diseases affecting the world’s poorest populations.

    Diagnostics often do not exist, are inaccessible, or cost too much. They remain under-resourced and overlooked, despite being pivotal for guiding the best treatment for individual patients; for preventing the spread of disease and antimicrobial resistance; and for enhancing surveillance for early disease detection and monitoring.

    With priorities aligned to those of the global public health community, we turn complex diagnostic challenges into simple solutions through unique partnerships with the public, private and non-profit sectors.

    Our work bridges R&D to access: we have deep technical and practical experience in the definition of needs, development of fit-for-purpose products...

    Main EU files targeted

    EU legislative proposals or policies we will engage with and advocate will relate to global health, international development, research & development, scientific innovation, human rights & gender issues, and the role of the EU and its member states in all of the above, as well as its implications and interactions with low and middle income countries (LMICS).
    Specifically, policy areas we will be involved with: the EU’s Global Approach on R&I, the new EU strategy with Africa and the EU communication on global health.
    Specific EU mechanisms and entities we have been and will be interacting with and aiming to engage with and advocate with include the Joint Undertakings Partnerships (such as EDCTP3), Innovative Medicines Initiative, HERA, the EU4HEALTH programme and Horizon Europe.

    Address

    Head Office
    Global Health CampusChemin du Pommier 40
    Le Grand Saconnex, Geneva 1218
    SWITZERLAND
    EU Office
    Global Health CampusChemin du Pommier 40
    Le Grand Saconnex, Geneva 1218
    SWITZERLAND

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    25%5

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 11 Dec 2024

    Name Start date End Date
    Willo BROCK 30 Jan 2024 04 Oct 2024

    Complementary Information

    We have 6 persons involved in EU-related policy, communications, advocacy, across our External Affairs Team.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    Partnerships are the core of our operating model. Our unique position, bridging the public and private sectors, allows us to bring a diverse set of stakeholders together to resolve technical, financial and logistical barriers to diagnostic innovation in low-resource settings.

    Our many partners include public, government donors, philanthropic organizations, commercial companies, academic and research institutions, international public health organizations (including non-governmental organizations and foundations), health ministries and disease control programmes.
    More information, including about our donors, is available here: https://www.finddx.org/partners-donors/

    Furthermore, FIND is member of the Global Health Technologies Coalition, Malaria No More, the Swiss Alliance on Neglected Tropical Diseases (SANTD), the Swiss Malaria Group, the G20 Health and Development Partnership, and the Chagas Coalition.

    Member organisations

    Our partner and donor organisations are listed here :https://www.finddx.org/partners-donors/

    We are also member of the Global Health Technologies Coalition, Malaria No More, the Swiss Alliance on Neglected Tropical Diseases (SANTD), the Swiss Malaria Group, the G20 Health and Development Partnership, and the Chagas Coalition.

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    53,934,067€

    Major funding types in closed year

    EU funding, Public funding

    Major contributions in closed year

    TypeNameAmount
    Contribution Bill & Melinda Gates Foundation 5,642,749€
    Contribution The Global Fund to Fight Aids, TB and Malaria 15,084,465€
    Contribution UK Foreign, Commonwealth & Development Office 9,576,357€
    Contribution Unitaid 7,732,765€
    Contribution Others 15,897,731€
    Grant European Union 637,878€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    Unofficial groupings

    Communication activities

    Our public relations and communication activities will be related to any of the above-mentioned areas of work/expertise. Specifically, we will engage with areas including international cooperation and external relations with LMICs, global health, research and innovation and gender and human rights.

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 22 Apr 2024 Location Brussels
      Subject Support of the European Framework Programme for health research and innovation
      Cabinet Cabinet of Commissioner Iliana Ivanova
      Attending
      • Nelly Bruno (Cabinet member)
      • Iliana Ivanova (Commissioner)
      Other Lobbyists
Download this datacard